Trademark Overview
On Tuesday, June 27, 2023, a trademark application was filed for SANEGENEBIO with the United States Patent and Trademark Office. The USPTO has given the SANEGENEBIO trademark a serial number of 98061872. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, October 24, 2024. This trademark is owned by Suzhou Sanegene Bio Inc.. The SANEGENEBIO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of various diseases, namely, rare {ocular, renal, muscular, metabolic, immune
system, cardiovascular, neurological and respiratory} diseases, genetic disorders, chronic liver diseases, cardiovascular diseases,
cancers, and viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, oligonucleotide compounds
for use in the targeted delivery of {Ribonucleic acid interference} (RNAi) therapy; Pharmaceutical preparations for use in {injection}
for treatment of rare {ocular, renal, muscular, metabolic, immune system, cardiovascular, neurological and respiratory} diseases,
genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical preparations for
pharmaceutical or medical purposes, namely, molecular nanoparticle complexes that act as a platform for the delivery of RNAbased drugs to biological cells; Drug delivery agents consisting of oligonucleotide compounds that facil...
